Literature DB >> 26287855

PCSK9 Inhibitors and Cardiovascular Events.

Johann Auer, Robert Berent, Carina Primus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26287855     DOI： 10.1056/NEJMc1508222

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

Review 1.  Alirocumab as add-on therapy to statins: current evidence and clinical potential.

Authors:  Johann Auer; Robert Berent
Journal:  Ther Adv Cardiovasc Dis       Date:  2018-05-24

Review 2.  PCSK9 inhibitors and cardiovascular disease: heralding a new therapeutic era.

Authors:  M John Chapman; Jane K Stock; Henry N Ginsberg
Journal:  Curr Opin Lipidol       Date:  2015-12       Impact factor: 4.776
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.